Determinants of Physician Ordering of Preoperative Autologous Donations

Preoperative autologous donation (PAD) is frequently utilized to reduce infectious disease transmission risks, but it is an expensive form of hemotherapy that is not always closely matched with the needs of the patients. We compared the use of PAD in an academic medical center with patient needs and then investigated the efficacy of a simple intervention to promote targeting of PAD toward patients most likely to benefit from having PADs available. Over a 3‐month period, surgeons whose patients received allogeneic components were asked to complete a questionnaire designed to identify reasons for not ordering PAD. PAD units were used in 14 (11%) of 124 cases, accounting for 6% of perioperative red cell use. The responses (46, 42% of the surveys sent) stated that PAD had not been ordered because of time constraints (39%), medical problems (26%), anemia (15%), and lack of expectation of blood use (24%). Chart review documented the presence of cited conditions in 88% of cases. Logistic and cost concerns were not evident. However, only 8% of the 176 PAD units collected in that period were transfused. Following dissemination of PAD ordering guidelines, this proportion rose to 52% without a reduction in the proportion of elective surgical cases utilizing autologous transfusion. This improvement in ordering practice was maintained over at least in 5‐month period. Thus we were able to improve the efficiency of PAD application (reducing over‐ordering) through a simple feedback to surgeons that assisted them in targeting PAD toward patients most likely to need transfusion.

[1]  E. L. Wallace,et al.  Collection and transfusion of blood and blood components in the United States, 1992 , 1995, Transfusion.

[2]  J. Avorn,et al.  A controlled trial of educational outreach to improve blood transfusion practice. , 1993, JAMA.

[3]  J. Birkmeyer,et al.  The cost‐effectiveness of preoperative autologous blood donation for total hip and knee replacement , 1993, Transfusion.

[4]  E. L. Wallace,et al.  Collection and transfusion of blood and blood components in the United States, 1989 , 1993, Transfusion.

[5]  E. Murphy,et al.  Cost–Benefit Analysis of Autologous Blood Donation in Obstetrics , 1992, Obstetrics and gynecology.

[6]  P. J. Howanitz,et al.  Preoperative autologous blood donation in 612 hospitals. A College of American Pathologists' Q-Probes study of quality issues in transfusion practice. , 1992, Archives of pathology & laboratory medicine.

[7]  D. Goldfinger,et al.  Don't forget the SOPCAB! , 1992, Transfusion.

[8]  B. Spiess,et al.  Autologous blood donation: hemodynamics in a high‐risk patient population , 1992, Transfusion.

[9]  R. Strauss,et al.  Probable reasons that autologous blood was not donated by patients having surgery for which crossmatched blood was ordered , 1991, Transfusion.

[10]  M. Kruskall.  On measuring the success of an autologous blood donation program , 1991, Transfusion.

[11]  D. Huestis,et al.  An autologous blood program coordinated by a regional blood center: a 5‐ year experience , 1991, Transfusion.

[12]  M. Popovsky,et al.  The safety of preoperative autologous blood donation in the nonhospital setting , 1991, Transfusion.

[13]  R. Strauss,et al.  Surgeons' knowledge, attitude, and use of preoperative autologous blood donation , 1990, Transfusion.

[14]  R. Strauss,et al.  Predeposited autologous blood for elective surgery. A national multicenter study. , 1987, The New England journal of medicine.

[15]  E. E. Glazer,et al.  Utilization and effectiveness of a hospital autologous preoperative blood donor program , 1986, Transfusion.

[16]  J B Henry,et al.  The type and screen: a safe alternative and supplement in selected surgical procedures , 1977, Transfusion.

[17]  collection and , 2022 .